期刊
ANTIVIRAL RESEARCH
卷 94, 期 2, 页码 179-183出版社
ELSEVIER
DOI: 10.1016/j.antiviral.2012.03.002
关键词
Japanese encephalitis virus; Envelope protein domain III; Antiviral peptide; Attachment
资金
- priority academic program development of Jiangsu Higher Education Institutions
- Nanjing Agricultural University [KYJ200911]
- National Institutes of Health (National Center for Research Resources) [2P41RR001081]
- National Institutes of Health (National Institute of General Medical Sciences) [9P41GM103311]
Japanese encephalitis virus (JEV) infection is a major cause of acute viral encephalitis both in humans and animals. The domain III of virus envelope protein (EDIII) plays important roles in interacting with host cell receptors to facilitate virus entry. In this study, recombinant JEV EDIII was expressed and purified. The protein showed the ability to inhibit JEV infection in BHK-21 cells with 50% inhibition at a concentration of 25 mu g/ml. Based on NMR structure of JEV EDIII, we chose several loop peptides that were reported to be related to receptor binding to test their possible inhibitory activities on virus infection. Our in vitro experiments demonstrated that one of the loop peptides (loop3) can prevent JEV infection with 50% inhibition at concentration of 10 mu M by interfering in virus attachment to the cells. Our in vivo experiments on mice showed the loop3 was the most protective peptide when administered before virus challenge. Therefore, the loop3 peptide may be served as basis for the development of novel antiviral agents against Japanese encephalitis virus or other flaviviruses infection. (C) 2012 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据